SocArXiv
Ivermectin and the odds of hospitalization due to COVID-19: evidence from a quasi-experimental analysis based on a public intervention in Mexico City
Ivermectin and the odds of hospitalization due to COVID.pdf
Version: 1
Submitted: May 03, 2021 | Last edited: June 29, 2021
https://osf.io/preprints/socarxiv/r93g4/Abstract
Objective
To measure the effect of Mexico City’s population-level intervention –an ivermectin-based Medical Kit – – in hospitalizations during the COVID-19 pandemic.
Methods
A quasi-experimental research design with a Coarsened Exact Matching method using administrative data from hospitals and phone-call monitoring. We estimated logistic-regression models with matched observations adjusting by age, sex, COVID severity, and comorbidities. For robustness checks separated the effect of the kit from phone medical monitoring; changed the comparison period; and subsetted the sample by hospitalization occupancy,
Results
We found a significant reduction in hospitalizations among patients who received the ivermectin-based medical kit; the range of the effect is 52%- 76% depending on model specification.
Conclusions
The study supports ivermectin-based interventions to assuage the effects of the COVID-19 pandemic on the health system.
